Alpine Immune Sciences, Inc. Forecasted to Earn Q1 2022 Earnings of ($0.27) Per Share (NASDAQ:ALPN)

Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) – Stock analysts at Wedbush issued their Q1 2022 earnings per share (EPS) estimates for shares of Alpine Immune Sciences in a research note issued to investors on Monday, March 21st. Wedbush analyst R. Driscoll anticipates that the biotechnology company will earn ($0.27) per share for the […]

Related Keywords

,Securities Exchange Commission ,Crossover Management ,Alpine Immune Sciences ,Zacks Investment Research ,Blackrock Inc ,Alpine Immune Sciences Inc ,Nasdaq ,Alpine Immune Sciences Get Rating ,Frazier Management ,Life Sciences Viiil Frazier ,Get Rating ,Immune Sciences ,Investment Research ,Life Sciences Viii ,Exchange Commission ,Nasdaq Alpn ,Alpn ,Medical ,Earnings Estimates ,Wedbush ,